title: Dysphoria induced in dialysis providers by secondary hyperparathyroidism.
authors.affiliation: Department of Medicine, New York University Langone Medical Center, New York, New York; and.
authors.forename: Irfana H
authors.initials: IH
authors.lastname: Soomro
authors.affiliation: Department of Medicine, New York University Langone Medical Center, New York, New York; and Nephrology Section, New York Harbor Veterans Affairs Health Care System, New York, New York david.goldfarb@va.gov.
authors.forename: David S
authors.initials: DS
authors.lastname: Goldfarb
mesh_terms: D057966:Calcimimetic Agents / Q000627:therapeutic use*; D019587:Dietary Supplements; D005260:Female; D006801:Humans; D006961:Hyperparathyroidism / Q000601:surgery*; D006962:Hyperparathyroidism, Secondary / Q000628:therapy*; D007676:Kidney Failure, Chronic / Q000628:therapy*; D008297:Male; D009281:Naphthalenes / Q000627:therapeutic use*; D010281:Parathyroid Hormone / Q000097:blood*; D016105:Parathyroidectomy / Q000639:trends*; D006435:Renal Dialysis / Q000009:adverse effects*; D051436:Renal Insufficiency, Chronic / Q000628:therapy*; D014807:Vitamin D / Q000627:therapeutic use*
chemical_list: D057966:Calcimimetic Agents; D009281:Naphthalenes; D010281:Parathyroid Hormone; D014807:Vitamin D
keywords: calcium; mineral metabolism; phosphate binders